Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis

International Journal of Food Microbiology

Volumn 149, Issue 1, 2011, Pages 45-49

  Philippe, David ^a   Heupel, Esther ^b   Blum Sperisen, Stephanie ^a   Riedel, Christian U ^b  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Bifidobacterium; Colitis; Inflammation

Indexed keywords

BIOLOGICAL MARKER; CYCLOOXYGENASE 2; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MYELOPEROXIDASE; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM BIFIDUM; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DRUG INHIBITION; ENTERITIS; HISTOPATHOLOGY; INFLAMMATION; MALE; MOUSE; NONHUMAN; TH1 CELL; WEIGHT REDUCTION;

ANIMALS; BIFIDOBACTERIUM; COLITIS; CROHN DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-1BETA; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; PROBIOTICS; T-LYMPHOCYTES, HELPER-INDUCER; TRINITROBENZENESULFONIC ACID;

ANIMALIA; BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM; MUS;

EID: 79960844328     PISSN: 01681605     EISSN: 18793460     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2010.12.020     Document Type: Article

References (36)

1. Ameho C.K., Adjei A.A., Harrison E.K., Takeshita K., Morioka T., Arakaki Y., Ito E., Suzuki I., Kulkarni A.D., Kawajiri A., Yamamoto S. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut 1997, 41:487-493.
2. Boirivant M., Strober W. The mechanism of action of probiotics. Current Opinion in Gastroenterology 2007, 23:679-692.
3. Bonizzi G., Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends in Immunology 2004, 25:280-288.
4. Cario E., Podolsky D.K. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infection and Immunity 2000, 68:7010-7017.
5. Di Giacinto C., Marinaro M., Sanchez M., Strober W., Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. Journal of Immunology 2005, 174:3237-3246.
6. Ewaschuk J.B., Diaz H., Meddings L., Diederichs B., Dmytrash A., Backer J., Looijer-van Langen M., Madsen K.L. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. American Journal of Physiology. Gastrointestinal and Liver Physiology 2008, 295:G1025-G1034.
7. Foligne B., Zoumpopoulou G., Dewulf J., Ben Younes A., Chareyre F., Sirard J.C., Pot B., Grangette C. A key role of dendritic cells in probiotic functionality. PLoS One. 2007, 2:e313.
8. Grangette C., Nutten S., Palumbo E., Morath S., Hermann C., Dewulf J., Pot B., Hartung T., Hols P., Mercenier A. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proceedings of the National Academy of Science of the United States of America 2005, 102:10321-10326.
9. Hart A.L., Lammers K., Brigidi P., Vitali B., Rizzello F., Gionchetti P., Campieri M., Kamm M.A., Knight S.C., Stagg A.J. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004, 53:1602-1609.
10. Heuvelin E., Lebreton C., Grangette C., Pot B., Cerf-Bensussan N., Heyman M. Mechanisms involved in alleviation of intestinal inflammation by Bifidobacterium breve soluble factors. PLoS One. 2009, 4:e5184.
11. Kim S.W., Kim H.M., Yang K.M., Kim S.A., Kim S.K., An M.J., Park J.J., Lee S.K., Kim T.I., Kim W.H., Cheon J.H. Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice. Inflammatory Bowel Disease 2010, 16:1514-1525.
12. Kobayashi Y. Neutrophil infiltration and chemokines. Critical Reviews in Immunology 2006, 26:307-316.
13. Konstantinov S.R., Smidt H., de Vos W.M., Bruijns S.C., Singh S.K., Valence F., Molle D., Lortal S., Altermann E., Klaenhammer T.R., van Kooyk Y. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proceedings of the National Academy of Science of the United States of America 2008, 105:19474-19479.
14. Kotlowski R., Bernstein C.N., Sepehri S., Krause D.O. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 2007, 56:669-675.
15. Krawisz J.E., Sharon P., Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984, 87:1344-1350.
16. Kwon H.K., Lee C.G., So J.S., Chae C.S., Hwang J.S., Sahoo A., Nam J.H., Rhee J.H., Hwang K.C., Im S.H. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proceedings of the National Academy of Science of the United States of America 2010, 107:2159-2164.
17. Leahy S.C., Higgins D.G., Fitzgerald G.F., van Sinderen D. Getting better with bifidobacteria. Journal of Applied Microbiology 2005, 98:1303-1315.
18. Lee B., Lee J.H., Lee H.S., Bae E.A., Huh C.S., Ahn Y.T., Kim D.H. Glycosaminoglycan degradation-inhibitory lactic acid bacteria ameliorate 2, 4, 6-trinitrobenzenesulfonic acid-induced colitis in mice. Journal of Microbiology and Biotechnology 2009, 19:616-621.
19. Lee I.A., Bae E.A., Lee J.H., Lee H., Ahn Y.T., Huh C.S., Kim D.H. Bifidobacterium longum HY8004 attenuates TNBS-induced colitis by inhibiting lipid peroxidation in mice. Inflammation Research 2010, 59:359-368.
20. Lupp C., Robertson M.L., Wickham M.E., Sekirov I., Champion O.L., Gaynor E.C., Finlay B.B. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host & Microbe 2007, 2:119-129.
21. Mane J., Loren V., Pedrosa E., Ojanguren I., Xaus J., Cabre E., Domenech E., Gassull M.A. Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice. Inflammatory Bowel Disease 2009, 15:1155-1163.
22. Meijssen M.A., Brandwein S.L., Reinecker H.C., Bhan A.K., Podolsky D.K. Alteration of gene expression by intestinal epithelial cells precedes colitis in interleukin-2-deficient mice. American Journal of Physiology. Gastrointestinal and Liver Physiology 1998, 274:G472-G479.
23. Mennigen R., Nolte K., Rijcken E., Utech M., Loeffler B., Senninger N., Bruewer M. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. American Journal of Physiology. Gastrointestinal and Liver Physiology 2009, 296:G1140-G1149.
24. Nanda Kumar N.S., Balamurugan R., Jayakanthan K., Pulimood A., Pugazhendhi S., Ramakrishna B.S. Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate. Journal of Gastroenterology and Hepatology 2008, 23:1834-1839.
25. Ortega-Cava C.F., Ishihara S., Rumi M.A., Kawashima K., Ishimura N., Kazumori H., Udagawa J., Kadowaki Y., Kinoshita Y. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. Journal of Immunology 2003, 170:3977-3985.
26. Peran L., Sierra S., Comalada M., Lara-Villoslada F., Bailon E., Nieto A., Concha A., Olivares M., Zarzuelo A., Xaus J., Galvez J. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. British Journal of Nutrition 2007, 97:96-103.
27. Picard C., Fioramonti J., Francois A., Robinson T., Neant F., Matuchansky C. Review article: bifidobacteria as probiotic agents - physiological effects and clinical benefits. Alimentary Pharmacology and Therapeutics 2005, 22:495-512.
28. Preising J., Philippe D., Gleinser M., Wei H., Blum S., Eikmanns B.J., Niess J.H., Riedel C.U. Selection of bifidobacteria for amelioration of murine colitis based on adhesion and anti-inflammatory capacity in vitro. Applied and Environmental Microbiology 2010, 76:3048-3051.
29. Riedel C.U., Foata F., Philippe D., Adolfsson O., Eikmanns B.J., Blum S. Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation. World Journal of Gastroenterology 2006, 12:3729-3735.
30. Roselli M., Finamore A., Nuccitelli S., Carnevali P., Brigidi P., Vitali B., Nobili F., Rami R., Garaguso I., Mengheri E. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflammatory Bowel Disease 2009, 15:1526-1536.
31. Schuppler M., Lotzsch K., Waidmann M., Autenrieth I.B. An abundance of Escherichia coli is harbored by the mucosa-associated bacterial flora of interleukin-2-deficient mice. Infection and Immunity 2004, 72:1983-1990.
32. Strober W., Fuss I.J., Blumberg R.S. The immunology of mucosal models of inflammation. Annual Review of Immunology 2002, 20:495-549.
33. van der Kleij H., O'Mahony C., Shanahan F., O'Mahony L., Bienenstock J. Protective effects of Lactobacillus reuteri and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2008, 295:R1131-R1137.
34. Wallace J.L., MacNaughton W.K., Morris G.P., Beck P.L. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 1989, 96:29-36.
35. Wohlgemuth S., Haller D., Blaut M., Loh G. Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice. Environmental Microbiology 2009, 11:1562-1571.
36. Yan F., Cao H., Cover T.L., Whitehead R., Washington M.K., Polk D.B. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007, 132:562-575.